Gaucher disease: a prototype for molecular medicine

This publication has 83 references indexed in Scilit:

• Synthesis and use of novel fluorescent glycosphingolipids for estimating β-glucosidase activity in vitro in the absence of detergents and subtyping Gaucher disease variants following administration into intact cells
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
• Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency
  Somatic Cell and Molecular Genetics, 1993
• Activator proteins and topology of lysosomal sphingolipid catabolism
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Genetic diagnosis of Gaucher's disease
  The Lancet, 1992
• Human acid β-glucosidase: use of sphingosyl and N-alkyl-glucosylamine inhibitors to investigate the properties of the active site
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
• Human acid β-glucosidase: Glycosylation is required for catalytic activity
  Biochemical and Biophysical Research Communications, 1990
• Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy
  Biochemical and Biophysical Research Communications, 1990
• Saposin D: A sphingomyelinase activator
  Biochemical and Biophysical Research Communications, 1988
• Spinal cord compression secondary to gaucher's disease
  Surgical Neurology, 1984
• Hematological findings in the Norrbottnian type of Gaucher disease
  European Journal of Pediatrics, 1982